Skip to content
DeepViews

Albemarle Corporation (ALB) — Analysis Summary

Albemarle Corporation (ALB) has a market cap of $16.21B with year-over-year revenue growth of -4.4%. Net margin stands at -9.9%. The stock trades at a P/E ratio of 72.3.

Key Takeaways

  • Revenue changed -4.4% year-over-year
  • Net margin of -9.9%
  • P/E ratio of 72.3

Compared to other companies in the PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS sector, ALB posted revenue growth of -4.4% and trades at a P/E of 72.3.

[XNYS]

Albemarle Corporation (ALB)

$137.36

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$16.21B
Enterprise Value
$16.45B
P/E Ratio
72.3
Div Yield
1.19%
EV/EBITDA
18.4
Company Profile
About
About Albemarle Corporation

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.

Sector

PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS

Employees

7,800

Headquarters

CHARLOTTE, NC

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
27
No Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$10.53B
Total Debt$1876.78M
Debt-to-Equity0.18
Cash & Equivalents$1631.69M

Cash Flow

Operating Cash Flow$1800.33M
Free Cash Flow$1342.37M
FCF Margin22.72%
P/FCF Ratio12.08
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$1.64

Dividend Yield

1.19%

Quarterly
Last Ex-Date: 2026-09-11

Dividend History

2026-09-11
CD$0.4100
2026-06-12
CD$0.4050
2026-03-13
CD$0.4050
2025-12-12
CD$0.4050
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.